The current study examined the effects of the NewGait™ device on walking performance in persons with multiple sclerosis (MS). Eight MS patients participated in this study. Pre- and post-testing assessed kinematic gait variables (step width, length, and speed), ankle range of motion, and rating of perceived exertion (RPE). Participants completed an 8-week physical therapy (PT) protocol aimed to improve gait and balance, with the experimental group wearing the NewGait™ device. Repeated measures mixed ANOVA showed no main effects between the gait variables or between groups. Post-hoc paired t-tests indicated that the NewGait™ device elicited meaningful change in left and right step length and speed. The NewGait™ device may be a promising rehabilitation device to help induce positive walking performance changes in persons with MS
